Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Cancer Medicine
|
August 11, 2018
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells
Karen A Cavassani, Rebecca J Meza, David M Habiel, et al.
Cancer Research
|
January 22, 2017
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis
Srinivas Nandana, Manisha Tripathi, Peng Duan, et al.
Endocrine-Related Cancer
|
November 25, 2025
Radiation reprograms fibroblasts to drive prostate cancer therapy resistance
Anisha Madhav, Manish Thiruvalluvan, Frank Duong, et al.
Cancer Cell
|
March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity
Jianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
The Journal of Clinical Investigation
|
July 27, 2018
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Rajeev Mishra, Subhash Haldar, Veronica Placencio, et al.
Oncogene
|
September 5, 2018
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Manabu Kato, Veronica R Placencio-Hickok, Anisha Madhav, et al.
JCI Insight
|
May 20, 2025
TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia
Hamed Khedmatgozar, Sayanika Dutta, Michael Dominguez, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Cancer Medicine
|
August 11, 2018
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells
Karen A Cavassani, Rebecca J Meza, David M Habiel, et al.
Cancer Research
|
January 22, 2017
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis
Srinivas Nandana, Manisha Tripathi, Peng Duan, et al.
Endocrine-Related Cancer
|
November 25, 2025
Radiation reprograms fibroblasts to drive prostate cancer therapy resistance
Anisha Madhav, Manish Thiruvalluvan, Frank Duong, et al.
Cancer Cell
|
March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity
Jianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
The Journal of Clinical Investigation
|
July 27, 2018
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
Rajeev Mishra, Subhash Haldar, Veronica Placencio, et al.
Oncogene
|
September 5, 2018
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Manabu Kato, Veronica R Placencio-Hickok, Anisha Madhav, et al.
JCI Insight
|
May 20, 2025
TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia
Hamed Khedmatgozar, Sayanika Dutta, Michael Dominguez, et al.
Page
of 3